Reducing Risky Drug Use Behaviors by Enrolling Syringe Exchange Registrants in Methadone Maintenance

References

• Adams, M., An, Q., Broz, D., Burnett, J., Wejnert, C., & Paz-Bailey, G, & NHBS Study Group. (2019). Distributive syringe sharing and use of syringe services programs (SSPs) among persons who inject drugs. AIDS and Behavior, 23(12), 3306–3314. https://doi.org/10.1007/s10461-019-02615-4
   PubMed Web of Science ®Google Scholar
• Aspinall, E. J., Nambiar, D., Goldberg, D. J., Hickman, M., Weir, A., Van Velzen, E., Palmateer, N., Doyle, J. S., Hellard, M. E., & Hutchinson, S. J. (2014). Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: A systematic review and meta-analysis. International Journal of Epidemiology, 43(1), 235–248. https://doi.org/10.1093/ije/dyt243
   PubMed Web of Science ®Google Scholar
• Bramson, H., Des Jarlais, D. C., Arasteh, K., Nugent, A., Guardino, V., Feelemyer, J., & Hodel, D. (2015). State laws, syringe exchange, and HIV among persons who inject drugs in the United States: History and effectiveness. Journal of Public Health Policy, 36(2), 212–230. https://doi.org/10.1057/jphp.2014.54
   PubMed Web of Science ®Google Scholar
• Brooner, R., Kidorf, M., King, V., Beilenson, P., Svikis, D., & Vlahov, D. (1998). Drug abuse treatment success among needle exchange participants. Public Health Reports, 113, 129–139. PMC1307735
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. (2020). Addressing the infectious disease consequences of the U.S. opioid crisis. U.S. Department of Health and Human Services. https://www.cdc.gov/nchhstp/budget/infographics/docs/NCHHSTP-opioids-P.pdf
   Google Scholar
• Corsi, K. F., Lehman, W. K., & Booth, R. E. (2009). The effect of methadone maintenance on positive outcomes for opiate injection drug users. Journal of Substance Abuse Treatment, 37(2), 120–126. https://doi.org/10.1016/j.jsat.2008.11.004
   PubMed Web of Science ®Google Scholar
• Des Jarlais, D. C., Braine, N., Yi, H., & Turner, C. (2007). Residual injection risk behavior, HIV infection, and the evaluation of syringe exchange programs. AIDS Education and Prevention: Official Publication of the International Society for AIDS Education, 19(2), 111–123. https://doi.org/10.1521/aeap.2007.19.2.111
   PubMed Web of Science ®Google Scholar
• Des Jarlais, D. C., McKnight, C., Goldblatt, C., & Purchase, D. (2009). Doing harm reduction better: Syringe exchange in the United States. Addiction (Abingdon, England), 104(9), 1441–1446. https://doi.org/10.1111/j.1360-0443.2008.02465.x
   PubMed Web of Science ®Google Scholar
• Gowing, L., Farrell, M. F., Bornemann, R., Sullivan, L. E., & Ali, R. (2011). Oral substitution treatment of injecting opioid users for prevention of HIV infection. Cochrane Database of Systematic Review, 8, Art No.: CD004145. https://doi.org/10.1002/14651858.CD004145.pub4
   Google Scholar
• Grau, L. E., Bluthenthal, R. N., Marshall, P., Singer, M., & Heimer, R. (2005). Psychosocial and behavioral differences among drug injectors who use and do not use syringe exchange programs. AIDS and Behavior, 9(4), 495–504. https://doi.org/10.1007/s10461-005-9020-3
   PubMed Web of Science ®Google Scholar
• Karki, P., Shrestha, R., Huedo-Medina, T. B., & Copenhaver, M. (2016). The impact of methadone maintenance treatment on HIV risk behaviors among high-risk injection drug users: A systematic review. Evidence-Based Medicine & Public Health, 2, pii: e1229. PMID: 27066590
   PubMedGoogle Scholar
• Kelly, S. M., O’Grady, K. E., Mitchell, S. G., Brown, B. S., & Schwartz, R. P. (2011). Predictors of methadone treatment retention from a multi-site study: A survival analysis. Drug and Alcohol Dependence, 117(2–3), 170–175. https://doi.org/10.1016/j.drugalcdep.2011.01.008
   PubMed Web of Science ®Google Scholar
• Kidorf, M., & King, V. L. (2008). Expanding the public health benefits of syringe exchange programs. Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie, 53(8), 487–495. https://doi.org/10.1177/070674370805300803
   PubMed Web of Science ®Google Scholar
• Kidorf, M., Brooner, R. K., Leoutsakos, J. M., & Peirce, J. (2018a). Treatment initiation strategies for syringe exchange referrals to methadone maintenance: A randomized clinical trial. Drug and Alcohol Dependence, 187, 343–350. https://doi.org/10.1016/j.drugalcdep.2018.03.009
   PubMed Web of Science ®Google Scholar
• Kidorf, M., King, V. L., Neufeld, K., Peirce, J., Kolodner, K., & Brooner, R. K. (2009). Improving substance abuse treatment enrollment in community syringe exchangers. Addiction, 104(5), 786–795. https://doi.org/10.1111/j.1360-0443.2009.02560.x
   PubMed Web of Science ®Google Scholar
• Kidorf, M., King, V. L., Peirce, J., Kolodner, K., & Brooner, R. K. (2011a). A treatment reengagement intervention for syringe exchangers. Journal of Substance Abuse Treatment, 41(4), 415–421. https://doi.org/10.1016/j.jsat.2011.06.008
   PubMed Web of Science ®Google Scholar
• Kidorf, M., King, V. L., Peirce, J., Pierce, J., Kolodner, K., & Brooner, R. K. (2011b). Benefits of concurrent syringe exchange and substance abuse treatment participation. Journal of Substance Abuse Treatment, 40(3), 265–271. https://doi.org/10.1016/j.jsat.2010.11.011
   PubMed Web of Science ®Google Scholar
• Kidorf, M., Solazzo, S., Yan, H., & Brooner, R. K. (2018b). Psychiatric and substance use comorbidity in treatment-seeking injection opioid users referred from syringe exchange. Journal of Dual Diagnosis, 14(4), 193–200. https://doi.org/10.1080/15504263.2018.1510148
   PubMed Web of Science ®Google Scholar
• Lansky, A., Finlayson, T., Johnson, C., Holtzman, D., Wejnert, C., Mitsch, A., Gust, D., Chen, R., Mizuno, Y., & Crepaz, N. (2014). Estimating the number of persons who inject drugs in the United States by meta-analysis to calculate national rates of HIV and Hepatitis C virus infections. PLoS One, 9(5), e97596. https://doi.org/10.1371/journal.Pone.0097596
   PubMed Web of Science ®Google Scholar
• McLellan, A. T., Lewis, D. C., O’Brien, C. P., & Kleber, H. D. (2000). Drug dependence, a chronic medical illness: Implications for treatment, insurance, and outcomes evaluation. JAMA, 284(13), 1689–1695. https://doi.org/10.1001/jama.284.13.1689
   PubMed Web of Science ®Google Scholar
• Metzger, D. (1993). The Risk Assessment Battery (RAB): Validity and reliability. In Presented at the annual meeting of the National Cooperative Vaccine Development Group for AIDS. Alexandria, VA: Alcohol and Drug Abuse Institute, University of Washington.
   Google Scholar
• Metzger, D. S., & Navaline, H. (2003). HIV prevention among injection drug users: The need for integrated models. Journal of Urban Health: Bulletin of the New York Academy of Medicine, 80(4 Suppl 3), iii59–66. https://doi.org/10.1093/jurban/jtg083
   PubMed Web of Science ®Google Scholar
• Millson, P., Challacombe, L., Villeneuve, P. J., Strike, C. J., Fischer, B., Myers, T., Shore, R., & Hopkins, S. (2007). Reduction in injection-related HIV risk after 6 months in a low-threshold methadone treatment program. AIDS Education and Prevention: Official Publication of the International Society for AIDS Education, 19(2), 124–136. https://doi.org/10.1521/aeap.2007.19.2.124
   PubMed Web of Science ®Google Scholar
• Neufeld, K., King, V., Peirce, J., Kolodner, K., Brooner, R., & Kidorf, M. (2008). A comparison of 1-year substance abuse treatment outcomes in community syringe exchange participants versus other referrals. Drug and Alcohol Dependence, 97(1–2), 122–129. https://doi.org/10.1016/j.drugalcdep.2008.03.026
   PubMed Web of Science ®Google Scholar
• Palmateer, N., Kimber, J., Hickman, M., Hutchinson, S., Rhodes, T., & Goldberg, D. (2010). Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: A review of reviews. Addiction (Abingdon, England), 105(5), 844–859. https://doi.org/10.1111/j.1360-0443.2009.02888.x
   PubMed Web of Science ®Google Scholar
• Proctor, S. L., Copeland, A. L., Kopak, A. M., Hoffmann, N. G., Herschman, P. L., & Polukhina, N. (2015). Predictors of patient retention in methadone maintenance treatment. Psychology of Addictive Behaviors: Journal of the Society of Psychologists in Addictive Behaviors, 29(4), 906–917. https://doi.org/10.1037/adb0000090
   PubMed Web of Science ®Google Scholar
• Schwartz, R. P., Gryczynski, J., O’Grady, K. E., Sharfstein, J. M., Warren, G., Olsen, Y., Mitchell, S. G., & Jaffe, J. H. (2013). Opioid agonist treatments and heroin overdose deaths in Baltimore, Maryland, 1995-2009. American Journal of Public Health, 103(5), 917–922. https://doi.org/10.2105/AJPH.2012.301049
   PubMed Web of Science ®Google Scholar
• Sordo, L., Barrio, G., Bravo, M. J., Indave, B. I., Degenhardt, L., Wiessing, L., Ferri, M., & Pastor-Barriuso, R. (2017). Mortality risk during and after opioid substitution treatment: Systematic review and meta-analysis of cohort studies. The BMJ, 357, j1550. https://doi.org/10.1136/bmj.j1550
   PubMed Web of Science ®Google Scholar
• Stone, A. C., Carroll, J. J., Rich, J. D., & Green, T. C. (2018). Methadone maintenance treatment among patients exposed to illicit fentanyl in Rhode Island: Safety, dose, retention, and relapse at 6 months. Drug and Alcohol Dependence, 192, 94–97. https://doi.org/10.1016/j.drugalcdep.2018.07.019
   PubMed Web of Science ®Google Scholar
• Tavitian-Exley, I., Vickerman, P., Bastos, F. I., & Boily, M. C. (2015). Influence of different drugs on HIV risk in people who inject: Systematic review and meta-analysis. Addiction (Abingdon, England), 110(4), 572–584. https://doi.org/10.1111/add.12846
   PubMed Web of Science ®Google Scholar
• Timko, C., Schultz, N. R., Cucciare, M. A., Vittorio, L., & Garrison-Diehn, C. (2016). Retention in medication-assisted treatment for opiate dependence: A systematic review. Journal of Addictive Diseases, 35(1), 22–35. https://doi.org/10.1080/10550887.2016.1100960
   PubMed Web of Science ®Google Scholar
• Van Den Berg, C., Smit, C., Van Brussel, G., Coutinho, R., & Prins, M., Amsterdam Cohort. (2007). Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: Evidence from the Amsterdam Cohort Studies among drug users. Addiction (Abingdon, England), 102(9), 1454–1462. https://doi.org/10.1111/j.1360-0443.2007.01912.x
   PubMed Web of Science ®Google Scholar
• Wechsberg, W. M., Lam, W. K., Zule, W., Hall, G., Middlesteadt, R., & Edwards, J. (2003). Violence, homelessness, and HIV risk among crack-using African-American women. Substance Use & Misuse, 38(3–6), 669–700. https://doi.org/10.1081/ja-120017389
   PubMed Web of Science ®Google Scholar